Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,067,201
-$130,607 QoQ
Shares Held
44,319
+3.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,289
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Focus Financial Network, Inc. holds $24,753,485 across 11 Drug Manufacturers - General names. PFE ranks #6 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,014 | $8,412,802 | |
| 2 | JNJ |
Johnson & Johnson
|
26,353 | $6,692,871 | |
| 3 | ABBV |
AbbVie Inc.
|
16,133 | $4,059,708 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,855 | $1,394,867 | |
| 5 | AMGN |
Amgen Inc
|
3,743 | $1,355,415 | |
| 6 | PFE |
Pfizer Inc
This page
|
44,319 | $1,067,201 | |
| 7 | NVO |
Novo Nordisk A S
|
17,017 | $815,794 | |
| 8 | NVS |
Novartis AG
|
2,032 | $318,455 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,067,201 | 44,319 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,197,808 | 42,657 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,406,302 | 56,478 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,202,248 | 47,184 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $1,237,912 | 51,069 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $1,204,207 | 47,522 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,244,654 | 46,915 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,504,388 | 51,983 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,612,207 | 57,620 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,681,344 | 60,589 | Shares | Sole | 2024-04-24 | |
| 2023-09-30 | $2,496,175 | 75,254 | Shares | Sole | 2024-07-23 | |
| 2023-06-30 | $2,433,791 | 66,352 | Shares | Sole | 2024-07-23 | |
| 2023-03-31 | $2,577,580 | 63,176 | Shares | Sole | 2024-07-23 | |
| 2022-12-31 | $3,197,376 | 62,400 | Shares | Sole | 2024-07-24 | |
| 2022-09-30 | $2,935,639 | 67,085 | Shares | Sole | 2024-07-24 | |
| 2022-06-30 | $3,488,325 | 66,533 | Shares | Sole | 2024-07-24 | |
| 2022-03-31 | $3,299,975 | 63,743 | Shares | Sole | 2024-07-24 | |
| 2021-12-31 | $4,469,730 | 75,694 | Shares | Sole | 2024-07-24 | |
| 2021-09-30 | $2,451,570 | 57,000 | Shares | Sole | 2024-07-24 | |
| 2021-06-30 | $2,255,224 | 57,590 | Shares | Sole | 2024-07-24 | |
| 2021-03-31 | $2,148,946 | 59,314 | Shares | Sole | 2024-07-24 | |
| 2020-12-31 | $1,929,285 | 52,412 | Shares | Sole | 2024-07-24 | |
| 2020-09-30 | $1,571,859 | 42,830 | Shares | Sole | 2024-07-24 | |
| 2020-06-30 | $1,309,701 | 40,052 | Shares | Sole | 2024-07-24 | |
| 2020-03-31 | $1,284,676 | 39,359 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||